Corporate Brochure
Corporate Video
Gallery
News & Updates
Home
About Akums
Company Profile
Formation
Mission and Vision
Leadership
Directors message
Leadership Team
Business Model
Awards and Accolades
Business Partners
Our Expertise
Manufacturing
Research & Development
Innovations
Quality
Regulatory
Units
Plant 1 (Solid Orals)
Plant 2 (Oral Liquids)
Plant 3 (Injectables)
Plant 4 (Hormonals)
Plant 5 (Ointment & Cosmetics)
Plant 6 (Maxcure Nutravedics Ltd)
Plant 7 (Pure and Cure)
Plant 8 (Malik Lifesciences)
Plant 9 (Pure Cure Guwahati)
Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
Centralised Stability Centre
Corporate Governance
Financial Statements
Shareholders Meetings
Corporate Social Responsibility
Environment Health & Safety
Disclosures
Global Presence
Careers
Working with us
Colors @ Akums
Current Openings
Events
Employee Recognition
Trainings
Gallery
News
Akums in News
Industry News
Blogs
Contact Us
Home
About Akums
Company Profile
Formation
Mission and Vision
Leadership
Directors message
Leadership Team
Business Model
Awards and Accolades
Business Partners
Our Expertise
Manufacturing
Research & Development
Innovations
Quality
Regulatory
Units
Plant 1 (Solid Orals)
Plant 2 (Oral Liquids)
Plant 3 (Injectables)
Plant 4 (Hormonals)
Plant 5 (Ointment & Cosmetics)
Plant 6 (Maxcure Nutravedics Ltd)
Plant 7 (Pure and Cure)
Plant 8 (Malik Lifesciences)
Plant 9 (Pure Cure Guwahati)
Plant 10 (Akums Healthcare Ltd (Sidcul Kotdwar))
Centralised Stability Centre
Corporate Governance
Financial Statements
Shareholders Meetings
Corporate Social Responsibility
Environment Health & Safety
Disclosures
Global Presence
Careers
Working with us
Colors @ Akums
Current Openings
Events
Employee Recognition
Trainings
Gallery
News
Akums in News
Industry News
Blogs
Contact Us
Akums in News
admin
2021-11-25T07:25:53+00:00
Devdiscourse (30th Nov 2022) – Akums Drugs & Pharmaceuticals partners with Leiutis Pharmaceuticals LLP, Biophore India Pharmaceuticals
Read More
Business Standard ( 27th Nov 22) : Akums chalks out expansion plan as it eyes Rs 10,000 CR turnover by 2028
Read More
The Economic Times ( 27th Nov 22) : Akums chalks out expansion plan as it eyes Rs 10K CR turnover by 2028
Read More
Medical Dialogues ( 27th Nov 22) : Akum Pharma Gets CDSCO Panel Nod to Manufacture, Market Anti-Hypertensive FDC Drug
Read More
ET Healthworld ( 25th Nov 22) : Revisiting the “One Dose for All” syndrome in developing pediatric medication.
Read More
Money Control ( 25th Nov 2022) – Akums, India’s largest contract manufacturer of drugs, plans European foray
Read More
Only My Health ( 24th Nov 22) – Nutrition Guide For Breast Cancer Patients: Foods To Eat And Avoid
Read More
Only My Health ( 24th Nov 22) – 4 Things To Keep In Mind During Pneumonia Recovery
Read More
Daily Pioneer ( 22nd Nov 2022) – DRUGS FOR KIDS MUST BE CHILD-CENTRIC
Read More
Money Control ( 21st Nov 2022) – Will pose an initial challenge, but a well-thought-out move, drug makers say of mandatory QR codes on branded medicines
Read More
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20